An alkaloid and antiarrhythmic agent
Related Products
Diastereomer(s)
46277Hydroquinine
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Hydroquinidine

Item No. 22295

Technical Information
Formal Name
10,11-dihydro-6'-methoxy-cinchonan-9S-ol
CAS Number
1435-55-8
Synonyms
  • Dihydroquinidine
  • (+)-Hydroquinidine
Molecular Formula
C20H26N2O2
Formula Weight
Purity
≥98%
A crystalline solid
DMF: 30 mg/mLDMF:PBS(pH7.2) (1:2): 0.33 mg/mLDMSO: 25 mg/mLEthanol: 1 mg/mL
λmax
233 nm
SMILES
COC1=CC=C2C(C([C@H](O)[C@@]3([H])C[C@H]4[C@@H](CC)C[N@@]3CC4)=CC=N2)=C1
InChi Code
InChI=1S/C20H26N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h4-6,8,11,13-14,19-20,23H,3,7,9-10,12H2,1-2H3/t13-,14-,19+,20-/m0/s1
InChi Key
LJOQGZACKSYWCH-LHHVKLHASA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Product Description

    Hydroquinidine is an alkaloid and derivative of the antiarrhythmic agent quinidine that decreases heart rate variability.1,2,3 It increases the length of the sinus cycle and prolongs QRS duration and ventricular repolarization in anesthetized dogs.2 It has also been imprinted on microspheres as a pseudo-template molecule for recognition of cinchona alkaloids.3 Formulations containing hydroquinidine have been studied for use in treatment of Brugada syndrome, which is a genetic disorder characterized by ventricular fibrillation and a risk of sudden death.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Chimienti, M., Regazzi, M.B., La Rovere, M.T., et alComparison of the effectiveness of dihydroquinidine and quinidine on ventricular ectopy after acute and chronic administration. Cardiovasc. Drugs Ther. 2(5), 679-686 (1988).

    2. Chézalviel, F., Weissenburger, J., Ertzbischoff, O., et alComparison of the cardiac electrophysiological effects of flecainide and hydroquinidine in anesthetized dog: Concentration-response relationship. J. Cardiovasc. Pharmacol. 15(1), 50-56 (1990).

    3. Zhou, Q., He, J., Tang, Y., et alA novel hydroquinidine imprinted microsphere using a chirality-matching N-acryloyl-L-phenylalanine monomer for recognition of cinchona alkaloids. J. Chromatogr. A. 1238, 60-67 (2012).

    4. Hermida, J.S., Denjoy, I., Clerc, J., et alHydroquinidine therapy in Brugada syndrome. J. Am. Coll. Cardiol. 43(10), 1853-1860 (2004).